Literature DB >> 21354228

A diagnostic approach to hyperferritinemia with a non-elevated transferrin saturation.

Paul C Adams1, James C Barton.   

Abstract

Elevated serum ferritin concentrations are common in clinical practice. In this review, we provide an approach to interpreting the serum ferritin elevation in relationship to other clinical parameters including the patient history, transferrin saturation, serum concentrations of alanine, and aspartate aminotransferases (ALT, AST), testing for HFE mutations, liver imaging, liver biopsy, and liver iron concentration. We used observations from a large series of patients with hepatic iron overload documented by liver iron concentration measurement from two referral practices as a gold standard to guide the interpretation of the predictive values of non-invasive iron tests. Three case studies illustrate common problems in interpreting iron blood tests.
Copyright © 2011 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21354228     DOI: 10.1016/j.jhep.2011.02.010

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  20 in total

1.  Probability of C282Y homozygosity decreases as liver transaminase activities increase in participants with hyperferritinemia in the hemochromatosis and iron overload screening study.

Authors:  Paul C Adams; Mark Speechley; James C Barton; Christine E McLaren; Gordon D McLaren; John H Eckfeldt
Journal:  Hepatology       Date:  2012-04-18       Impact factor: 17.425

2.  Serum ferritin, insulin resistance, and metabolic syndrome: clinical and laboratory associations in 769 non-hispanic whites without diabetes mellitus in the HEIRS study.

Authors:  Ronald T Acton; J Clayborn Barton; James C Barton
Journal:  Metab Syndr Relat Disord       Date:  2014-11-25       Impact factor: 1.894

3.  Serum Iron and Ferritin Levels Are Correlated with Complement C3.

Authors:  Shuang Wen; Yeqin Sha; Yinling Li; Zhilian Rui; Chenhong Si; Yuning Zhou; Fengfeng Yan; Bicheng Wang; Jingming Hu; Xu Han; Dongyan Shi
Journal:  Biol Trace Elem Res       Date:  2020-09-15       Impact factor: 3.738

4.  Increased serum hepcidin levels in subjects with the metabolic syndrome: a population study.

Authors:  Nicola Martinelli; Michela Traglia; Natascia Campostrini; Ginevra Biino; Michela Corbella; Cinzia Sala; Fabiana Busti; Corrado Masciullo; Daniele Manna; Sara Previtali; Annalisa Castagna; Giorgio Pistis; Oliviero Olivieri; Daniela Toniolo; Clara Camaschella; Domenico Girelli
Journal:  PLoS One       Date:  2012-10-29       Impact factor: 3.240

5.  Elevated serum transaminase activities were associated with increased serum levels of iron regulatory hormone hepcidin and hyperferritinemia risk.

Authors:  Peng An; Hao Wang; Qian Wu; Xin Guo; Aimin Wu; Zhou Zhang; Di Zhang; Xiaochen Xu; Qianyun Mao; Xiaoyun Shen; Lihong Zhang; Zhiqi Xiong; Lin He; Yun Liu; Junxia Min; Daizhan Zhou; Fudi Wang
Journal:  Sci Rep       Date:  2015-08-20       Impact factor: 4.379

6.  Hereditary hemochromatosis.

Authors:  Stephen A Geller; Fernando P F de Campos
Journal:  Autops Case Rep       Date:  2015-03-30

Review 7.  Diabetes in HFE Hemochromatosis.

Authors:  James C Barton; Ronald T Acton
Journal:  J Diabetes Res       Date:  2017-02-26       Impact factor: 4.011

Review 8.  Hyperferritinemia-A Clinical Overview.

Authors:  Miriam Sandnes; Rune J Ulvik; Marta Vorland; Håkon Reikvam
Journal:  J Clin Med       Date:  2021-05-07       Impact factor: 4.241

9.  EMQN best practice guidelines for the molecular genetic diagnosis of hereditary hemochromatosis (HH).

Authors:  Graça Porto; Pierre Brissot; Dorine W Swinkels; Heinz Zoller; Outi Kamarainen; Simon Patton; Isabel Alonso; Michael Morris; Steve Keeney
Journal:  Eur J Hum Genet       Date:  2015-07-08       Impact factor: 4.246

10.  Reversal of end-stage heart failure in juvenile hemochromatosis with iron chelation therapy: a case report.

Authors:  Shamil D Cooray; Neel M Heerasing; Laura A Selkrig; V Nathan Subramaniam; P Shane Hamblin; Cameron J McDonald; Catriona A McLean; Elissa McNamara; Angeline S Leet; Stuart K Roberts
Journal:  J Med Case Rep       Date:  2018-01-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.